Cargando…
Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
2018 was the year of the first marketing authorization of an allogeneic stem cell therapy by the European Medicines Agency. The authorization concerns the use of allogeneic adipose tissue‐derived mesenchymal stromal cells (MSCs) for treatment of complex perianal fistulas in Crohn's disease. Thi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811696/ https://www.ncbi.nlm.nih.gov/pubmed/31282113 http://dx.doi.org/10.1002/sctm.19-0073 |